HuagongsheHuagongshe Chemistry Print Report · For research reference only
Potassium Hydroxide → HCID 86711095, compound
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | Potassium Hydroxide | HCID 14797 | — |
| Reactant | Chloromethyl 2-{[(tert-butoxy)carbonyl]amino}-2-methylpropanoate | HCID 11776960 | — |
| Reactant | Vemurafenib | HCID 42611257 | — |
| Solvent | Dimethylformamide | HCID 6228 | — |
| Product | HCID 86711095 | HCID 86711095 | — |
Reaction Steps
The title compound was prepared according to the procedure as described in Example 14 Step 2 using N-(3-(5-(4-chlorophenyl)-1H-pyrrolo[2,3-b]pyridine-3-carbonyl)-2,4-difluorophenyl)propane-1-sulfonamide (0.3 g, 0.61 mmol) in DMF (2.5 mL), KOH (69 mg, 0.4 mmol), and a solution of chloromethyl 2-((tert-butoxycarbonyl)amino)-2-methylpropanoate (158 mg, 0.61 mmol) in DMF (0.5 mL). The title compound was purified by a silica gel columnchromatography (PE/EtOAc (v/v)=4/1 to 3/1) and was obtained as a white solid (339 mg, 78.7%). The title compound was characterized by LC-MS and 1H NMR as shown below:
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US09399639B2 |
| Source dataset | uspto-grants-2016_07 |
| ORD ID | ord-f505f0da4096488d817c1a679b6567ab |
| Source note | uspto-grants-2016_07 |